deltatrials
Completed OBSERVATIONAL NCT03894878

Association Between Genetic Variant Scores and Warfarin Effect (AWARE1)

Association Between Risk Scores for Genetic Variants and Percentage of Time in Therapeutic Range for Participants With Atrial Fibrillation, Deep Vein Thrombosis, and/or Intracardiac Thrombosis Taking Warfarin

Sponsor: Cipherome, Inc.

Conditions Atrial Fibrillation Deep Vein Thrombosis Intracardiac Thrombus Pulmonary Embolism Venous Thromboembolic Disease
Updated 12 times since 2019 Last updated: Feb 14, 2023 Started: Feb 11, 2019 Primary completion: Sep 30, 2022 Completion: Sep 30, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03894878, this observational or N/A phase trial focuses on Atrial Fibrillation and Deep Vein Thrombosis and remains completed. Sponsored by Cipherome, Inc., it has been updated 12 times since 2019, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Apr 2019 – ~May 2019 · 30 days · monthly snapshotRecruiting~May 2019 – ~Aug 2019 · 3 months · monthly snapshotRecruiting~Aug 2019 – ~Nov 2020 · 15 months · monthly snapshotRecruiting~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotRecruiting~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshotRecruiting~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshotRecruiting~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshotRecruiting~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshotRecruiting~Sep 2022 – ~Mar 2023 · 6 months · monthly snapshotRecruiting~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Mar 2023 — Jul 2024 [monthly]

    Completed

    Status: Recruiting → Completed

  4. Sep 2022 — Mar 2023 [monthly]

    Recruiting

  5. Apr 2022 — Sep 2022 [monthly]

    Recruiting

▶ Show 7 earlier versions

  1. Dec 2021 — Apr 2022 [monthly]

    Recruiting

  2. Oct 2021 — Dec 2021 [monthly]

    Recruiting

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting

  4. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  5. Aug 2019 — Nov 2020 [monthly]

    Recruiting

  6. May 2019 — Aug 2019 [monthly]

    Recruiting

  7. Apr 2019 — May 2019 [monthly]

    Recruiting

    First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cipherome, Inc.
  • Santa Clara Valley Medical Center
Data source: Cipherome, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations